Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

2.
3.

[Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].

Porjazova E, Zaprjanov Z, Batashki I, Markova D, Milchev N.

Akush Ginekol (Sofiia). 2009;48(2):7-12. Bulgarian.

PMID:
20198769
4.

Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.

Chou YY, Jeng YM, Kao HL, Chen T, Mao TL, Lin MC.

Histopathology. 2003 Aug;43(2):151-6.

PMID:
12877730
5.

CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.

Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.

Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150.

PMID:
19926591
6.

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.

Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.

Am J Surg Pathol. 2016 Mar;40(3):419-32. doi: 10.1097/PAS.0000000000000553.

PMID:
26551622
8.

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.

Diagn Mol Pathol. 2001 Jun;10(2):116-22.

PMID:
11385321
9.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
10.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
11.

p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.

Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.

Am J Surg Pathol. 2007 May;31(5):653-63.

PMID:
17460447
12.
15.

Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum.

Groisman GM, Bernheim J, Halpern M, Brazowsky E, Meir A.

Arch Pathol Lab Med. 2005 Jul;129(7):920-3.

PMID:
15974817
16.

Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma.

Albarracin CT, Jafri J, Montag AG, Hart J, Kuan SF.

Hum Pathol. 2000 Jun;31(6):672-7.

PMID:
10872659
17.

The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.

Perez Montiel D, Arispe Angulo K, Cantú-de León D, Bornstein Quevedo L, Chanona Vilchis J, Herrera Montalvo L.

Ann Diagn Pathol. 2015 Aug;19(4):249-52. doi: 10.1016/j.anndiagpath.2015.05.004.

PMID:
26059401
18.

CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.

Barbareschi M, Murer B, Colby TV, Chilosi M, Macri E, Loda M, Doglioni C.

Am J Surg Pathol. 2003 Feb;27(2):141-9.

PMID:
12548159
19.

CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.

Fraggetta F, Pelosi G, Cafici A, Scollo P, Nuciforo P, Viale G.

Virchows Arch. 2003 Dec;443(6):782-6.

PMID:
14576939
20.

Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.

Baker PM, Oliva E.

Int J Gynecol Pathol. 2005 Jan;24(1):39-55. Review.

PMID:
15626916
Items per page

Supplemental Content

Support Center